Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-079768
Filing Date
2025-05-30
Accepted
2025-05-30 16:30:56
Documents
18
Effectiveness Date
2025-05-30

Document Format Files

Seq Description Document Type Size
1 S-8 stro-20250530.htm S-8 111032
2 EX-5.1 stro-ex5_1.htm EX-5.1 18443
3 EX-23.1 stro-ex23_1.htm EX-23.1 4748
4 EX-99.1 stro-ex99_1.htm EX-99.1 176396
5 EX-99.2 stro-ex99_2.htm EX-99.2 113289
6 EX-99.3 stro-ex99_3.htm EX-99.3 129717
7 EX-FILING FEES stro_exfilingfees.htm   iXBRL EX-FILING FEES 34440
8 GRAPHIC img4916824_0.jpg GRAPHIC 29255
  Complete submission text file 0000950170-25-079768.txt   755246

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT stro_exfilingfees_htm.xml XML 8472
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287688 | Film No.: 251011469
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)